ID: ALA371655

Max Phase: Preclinical

Molecular Formula: C35H40N4O2

Molecular Weight: 548.73

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCN1[C@H](C)CN(c2cc3c(cc2OC)CCN3C(=O)c2ccc(-c3cccc(C)n3)c3ccccc23)C[C@@H]1C

Standard InChI:  InChI=1S/C35H40N4O2/c1-6-17-38-24(3)21-37(22-25(38)4)33-20-32-26(19-34(33)41-5)16-18-39(32)35(40)30-15-14-29(27-11-7-8-12-28(27)30)31-13-9-10-23(2)36-31/h7-15,19-20,24-25H,6,16-18,21-22H2,1-5H3/t24-,25+

Standard InChI Key:  ZWKRKMCSEOLRAV-PLQXJYEYSA-N

Associated Targets(Human)

Serotonin 1a (5-HT1a) receptor 14969 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 1b (5-HT1b) receptor 2801 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 1d (5-HT1d) receptor 2897 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 1 receptors; 5-HT1B & 5-HT1D 345 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 548.73Molecular Weight (Monoisotopic): 548.3151AlogP: 6.73#Rotatable Bonds: 6
Polar Surface Area: 48.91Molecular Species: BASEHBA: 5HBD: 0
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.51CX LogP: 6.42CX LogD: 5.27
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.27Np Likeness Score: -1.07

References

1. Wyman PA, Marshall HR, Flynn ST, King RJ, Thompson M, Smith PW, Hadley MS, Price GW, Scott CM, Dawson LA..  (2005)  Identification of a potent and selective 5-HT1B receptor antagonist.,  15  (21): [PMID:16153839] [10.1016/j.bmcl.2005.07.085]

Source